July 4, 2024 10:20 pm
Health concerns prompt FDA recall of mushroom products

In the humidified “fruiting chamber” of a private home in Fairfield County, Connecticut, psilocybin mushrooms are being grown. These mushrooms, also known as “magic mushrooms,” have shown potential in treating a variety of mental health conditions including anxiety, anorexia, depression, PTSD, obsessive-compulsive disorder, and substance abuse. Studies suggest that psilocybin may promote neuroplasticity, which is the rewiring of the brain to provide patients with new perspectives on long-standing psychiatric issues.

While psilocybin is classified as a Schedule 1 substance in the U.S., making it illegal federally, many municipalities in the United States and Colorado have decriminalized it locally. Oregon has even legalized the adult use of mushrooms within regulated “psilocybin service centers.” However, not all companies are operating within these regulations.

In recent news, Prophet Premium Blends has issued a recall for its Diamond Shruumz-infused cones, chocolate bars, and gummies due to the presence of muscimol. This compound can lead to seizures, loss of consciousness, nausea, vomiting

Leave a Reply